{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T07:25:16Z","timestamp":1794209116399,"version":"4.8.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372968"],"award-info":[{"award-number":["82372968"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medical Engineering Jiont Fund of Fudan University","award":["XM03231533"],"award-info":[{"award-number":["XM03231533"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>Glucose starvation induces the accumulation of disulfides and F-actin collapse in cells with high expression of SLC7A11, a phenomenon termed disulfidptosis. This study aimed to confirm the existence of disulfidptosis in pancreatic ductal adenocarcinoma (PDAC) and elucidate the role of Cancer Susceptibility 8 (CASC8) in this process.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The existence of disulfidptosis in PDAC was assessed using flow cytometry and F-actin staining. CASC8 expression and its clinical correlations were analyzed using data from The Cancer Genome Atlas (TCGA) and further verified by chromogenic in situ hybridization assay in PDAC tissues. Cells with CASC8 knockdown and overexpression were subjected to cell viability, EdU, transwell assays, and used to establish subcutaneous and orthotopic tumor models. Disulfidptosis was detected by flow cytometry and immunofluorescence assays. RNA sequencing and metabolomics analysis were performed to determine the metabolic pathways which were significantly affected after CASC8 knockdown. We detected the glucose consumption and the NADP<jats:sup>+<\/jats:sup>\/NADPH ratio to investigate alterations in metabolic profiles. RNA immunoprecipitation combined with fluorescence in situ hybridization assay was used to identify protein-RNA interactions. Protein stability, western blotting and quantitative real-time PCR assays were performed to reveal potential molecular mechanism.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Disulfidptosis was observed in PDAC and could be significantly rescued by disulfidptosis inhibitors. CASC8 expression was higher in PDAC samples compared to normal pancreatic tissue. High CASC8 expression correlated with a poor prognosis for patients with PDAC and contributed to cancer progression in vitro and in vivo. Furthermore, CASC8 was associated with disulfidptosis resistance under glucose starvation conditions in PDAC. Mechanistically, CASC8 interacted with c-Myc to enhance the stability of c-Myc protein, leading to the activation of the pentose phosphate pathway, a reduction of the NADP<jats:sup>+<\/jats:sup>\/NADPH ratio and ultimately inhibiting disulfidptosis under glucose starvation conditions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>This study provides evidence for the existence of disulfidptosis in PDAC and reveals the upregulation of CASC8 in this malignancy. Furthermore, we demonstrate that CASC8 acts as a crucial regulator of the pentose phosphate pathway and disulfidptosis, thereby promoting PDAC progression.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13046-025-03295-w","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T02:25:14Z","timestamp":1737944714000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["CASC8 activates the pentose phosphate pathway to inhibit disulfidptosis in pancreatic ductal adenocarcinoma though the c-Myc-GLUT1 axis"],"prefix":"10.1186","volume":"44","author":[{"given":"Hong-Fei","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieqiong","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunjing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abousalam Abdoulkader","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlong","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guihua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongyi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,27]]},"reference":[{"issue":"1","key":"3295_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"3295_CR2","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1053\/j.gastro.2020.02.068","volume":"159","author":"M Arnold","year":"2020","unstructured":"Arnold M, Abnet CC, Neale RE, Vignat J, Giovannucci EL, McGlynn KA, Bray F. Global Burden of 5 Major Types of Gastrointestinal Cancer. Gastroenterology. 2020;159(1):335-349.e315.","journal-title":"Gastroenterology"},{"issue":"4","key":"3295_CR3","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1158\/1078-0432.CCR-23-2098","volume":"30","author":"D Wei","year":"2024","unstructured":"Wei D, Wang L, Zuo X, Maitra A, Bresalier RS. A Small Molecule with Big Impact: MRTX1133 Targets the KRASG12D Mutation in Pancreatic Cancer. Clin Cancer Res. 2024;30(4):655\u201362.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"3295_CR4","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1158\/2159-8290.CD-23-0584","volume":"14","author":"W Sang","year":"2024","unstructured":"Sang W, Zhou Y, Chen H, Yu C, Dai L, Liu Z, Chen L, Fang Y, Ma P, Wu X, et al. Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer. Cancer Discov. 2024;14(2):326\u201347.","journal-title":"Cancer Discov"},{"issue":"5","key":"3295_CR5","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s13402-023-00824-7","volume":"46","author":"S Zhang","year":"2023","unstructured":"Zhang S, Yao HF, Li H, Su T, Jiang SH, Wang H, Zhang ZG, Dong FY, Yang Q, Yang XM. Transglutaminases are oncogenic biomarkers in human cancers and therapeutic targeting of TGM2 blocks chemoresistance and macrophage infiltration in pancreatic cancer. Cell Oncol (Dordr). 2023;46(5):1473\u201392.","journal-title":"Cell Oncol (Dordr)"},{"issue":"16\u201318","key":"3295_CR6","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1089\/ars.2022.0101","volume":"37","author":"L Li","year":"2022","unstructured":"Li L, Yu XJ, Gao L, Cheng L, Sun B, Wang G. Diabetic Ferroptosis and Pancreatic Cancer: Foe or Friend? Antioxid Redox Signal. 2022;37(16\u201318):1206\u201321.","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"3295_CR7","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12943-019-1029-8","volume":"18","author":"Y Gong","year":"2019","unstructured":"Gong Y, Fan Z, Luo G, Yang C, Huang Q, Fan K, Cheng H, Jin K, Ni Q, Yu X, et al. The role of necroptosis in cancer biology and therapy. Mol Cancer. 2019;18(1):100.","journal-title":"Mol Cancer"},{"issue":"11","key":"3295_CR8","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/s41575-021-00486-6","volume":"18","author":"X Chen","year":"2021","unstructured":"Chen X, Zeh HJ, Kang R, Kroemer G, Tang D. Cell death in pancreatic cancer: from pathogenesis to therapy. Nat Rev Gastroenterol Hepatol. 2021;18(11):804\u201323.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"3295_CR9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.31083\/j.fbl2901045","volume":"29","author":"C Yang","year":"2024","unstructured":"Yang C, Dong Q, Bao H, Ge Y, Xu Z, Li J, Jiang X, Xu Y, Zhong X. Ferroptosis: New Strategies and Ideas for the Treatment of Pancreatic Ductal Adenocarcinoma. Front Biosci (Landmark Ed). 2024;29(1):45.","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"18","key":"3295_CR10","doi-asserted-by":"publisher","first-page":"8813","DOI":"10.7150\/thno.62521","volume":"11","author":"SK Hsu","year":"2021","unstructured":"Hsu SK, Li CY, Lin IL, Syue WJ, Chen YF, Cheng KC, Teng YN, Lin YH, Yen CH, Chiu CC. Inflammation-related pyroptosis, a novel programmed cell death pathway, and its crosstalk with immune therapy in cancer treatment. Theranostics. 2021;11(18):8813\u201335.","journal-title":"Theranostics"},{"key":"3295_CR11","doi-asserted-by":"publisher","first-page":"847345","DOI":"10.3389\/fimmu.2022.847345","volume":"13","author":"J Liu","year":"2022","unstructured":"Liu J, Hong M, Li Y, Chen D, Wu Y, Hu Y. Programmed Cell Death Tunes Tumor Immunity. Front Immunol. 2022;13:847345.","journal-title":"Front Immunol."},{"issue":"1","key":"3295_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s13402-022-00741-1","volume":"46","author":"YH Zhu","year":"2023","unstructured":"Zhu YH, Zheng JH, Jia QY, Duan ZH, Yao HF, Yang J, Sun YW, Jiang SH, Liu DJ, Huo YM. Immunosuppression, immune escape, and immunotherapy in pancreatic cancer: focused on the tumor microenvironment. Cell Oncol (Dordr). 2023;46(1):17\u201348.","journal-title":"Cell Oncol (Dordr)"},{"issue":"3","key":"3295_CR13","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41556-023-01091-2","volume":"25","author":"X Liu","year":"2023","unstructured":"Liu X, Nie L, Zhang Y, Yan Y, Wang C, Colic M, Olszewski K, Horbath A, Chen X, Lei G, et al. Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis. Nat Cell Biol. 2023;25(3):404\u201314.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"3295_CR14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13046-023-02675-4","volume":"42","author":"P Zheng","year":"2023","unstructured":"Zheng P, Zhou C, Ding Y, Duan S. Disulfidptosis: a new target for metabolic cancer therapy. J Exp Clin Cancer Res. 2023;42(1):103.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"3295_CR15","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s12935-024-03374-6","volume":"24","author":"H Yao","year":"2024","unstructured":"Yao H, Liu P, Yao L, Li X. Establishment of disulfidptosis-related LncRNA signature as biomarkers in colon adenocarcinoma. Cancer Cell Int. 2024;24(1):183.","journal-title":"Cancer Cell Int"},{"issue":"5","key":"3295_CR16","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1053\/j.gastro.2022.06.058","volume":"163","author":"Z Zhou","year":"2022","unstructured":"Zhou Z, Ren Y, Yang J, Liu M, Shi X, Luo W, Fung KM, Xu C, Bronze MS, Zhang Y, et al. Acetyl-Coenzyme A Synthetase 2 Potentiates Macropinocytosis and Muscle Wasting Through Metabolic Reprogramming in Pancreatic Cancer. Gastroenterology. 2022;163(5):1281-1293.e1281.","journal-title":"Gastroenterology"},{"issue":"16","key":"3295_CR17","doi-asserted-by":"publisher","first-page":"e2119168119","DOI":"10.1073\/pnas.2119168119","volume":"119","author":"MM LaRue","year":"2022","unstructured":"LaRue MM, Parker S, Puccini J, Cammer M, Kimmelman AC, Bar-Sagi D. Metabolic reprogramming of tumor-associated macrophages by collagen turnover promotes fibrosis in pancreatic cancer. Proc Natl Acad Sci U S A. 2022;119(16):e2119168119.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3295_CR18","doi-asserted-by":"publisher","first-page":"111798","DOI":"10.1016\/j.biopha.2021.111798","volume":"141","author":"X Hao","year":"2021","unstructured":"Hao X, Ren Y, Feng M, Wang Q, Wang Y. Metabolic reprogramming due to hypoxia in pancreatic cancer: Implications for tumor formation, immunity, and more. Biomed Pharmacother. 2021;141:111798.","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"3295_CR19","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1007\/s13402-023-00821-w","volume":"46","author":"YY Wang","year":"2023","unstructured":"Wang YY, Zhou YQ, Xie JX, Zhang X, Wang SC, Li Q, Hu LP, Jiang SH, Yi SQ, Xu J, et al. MAOA suppresses the growth of gastric cancer by interacting with NDRG1 and regulating the Warburg effect through the PI3K\/AKT\/mTOR pathway. Cell Oncol (Dordr). 2023;46(5):1429\u201344.","journal-title":"Cell Oncol (Dordr)"},{"issue":"1","key":"3295_CR20","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s13402-023-00852-3","volume":"47","author":"PC Chen","year":"2024","unstructured":"Chen PC, Ning Y, Li H, Su JG, Shen JB, Feng QC, Jiang SH, Shi PD, Guo RS. Targeting ONECUT3 blocks glycolytic metabolism and potentiates anti-PD-1 therapy in pancreatic cancer. Cell Oncol (Dordr). 2024;47(1):81\u201396.","journal-title":"Cell Oncol (Dordr)"},{"issue":"2","key":"3295_CR21","doi-asserted-by":"publisher","first-page":"387","DOI":"10.7150\/jca.47863","volume":"12","author":"X Jiang","year":"2021","unstructured":"Jiang X, Guan J, Xu Y, Ren H, Jiang J, Wudu M, Wang Q, Su H, Zhang Y, Zhang B, et al. Silencing of CASC8 inhibits non-small cell lung cancer cells function and promotes sensitivity to osimertinib via FOXM1. J Cancer. 2021;12(2):387\u201396.","journal-title":"J Cancer"},{"issue":"13","key":"3295_CR22","doi-asserted-by":"publisher","first-page":"4824","DOI":"10.7150\/ijbs.71234","volume":"18","author":"Q Wu","year":"2022","unstructured":"Wu Q, Zhang H, Yang D, Min Q, Wang Y, Zhang W, Zhan Q. The m6A-induced lncRNA CASC8 promotes proliferation and chemoresistance via upregulation of hnRNPL in esophageal squamous cell carcinoma. Int J Biol Sci. 2022;18(13):4824\u201336.","journal-title":"Int J Biol Sci"},{"issue":"7\u20138","key":"3295_CR23","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1007\/s10495-023-01843-3","volume":"28","author":"HF Yao","year":"2023","unstructured":"Yao HF, Xu DP, Zheng JH, Xu Y, Jia QY, Zhu YH, Yang J, He RZ, Ma D, Yang MW, et al. Analysis of cuproptosis-related lncRNA signature for predicting prognosis and tumor immune microenvironment in pancreatic cancer. Apoptosis. 2023;28(7\u20138):1090\u2013112.","journal-title":"Apoptosis"},{"issue":"8","key":"3295_CR24","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.tibs.2014.06.005","volume":"39","author":"KC Patra","year":"2014","unstructured":"Patra KC, Hay N. The pentose phosphate pathway and cancer. Trends Biochem Sci. 2014;39(8):347\u201354.","journal-title":"Trends Biochem Sci"},{"issue":"8","key":"3295_CR25","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1038\/s12276-023-01069-y","volume":"55","author":"E Lee","year":"2023","unstructured":"Lee E, Song CH, Bae SJ, Ha KT, Karki R. Regulated cell death pathways and their roles in homeostasis, infection, inflammation, and tumorigenesis. Exp Mol Med. 2023;55(8):1632\u201343.","journal-title":"Exp Mol Med"},{"issue":"Pt 3","key":"3295_CR26","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.semcancer.2022.07.007","volume":"86","author":"T Zhang","year":"2022","unstructured":"Zhang T, Wang Y, Inuzuka H, Wei W. Necroptosis pathways in tumorigenesis. Semin Cancer Biol. 2022;86(Pt 3):32\u201340.","journal-title":"Semin Cancer Biol"},{"issue":"6","key":"3295_CR27","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1097\/CM9.0000000000002239","volume":"136","author":"L Gong","year":"2023","unstructured":"Gong L, Huang D, Shi Y, Liang Z, Bu H. Regulated cell death in cancer: from pathogenesis to treatment. Chin Med J (Engl). 2023;136(6):653\u201365.","journal-title":"Chin Med J (Engl)"},{"issue":"9","key":"3295_CR28","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/s41573-023-00749-8","volume":"22","author":"K Hadian","year":"2023","unstructured":"Hadian K, Stockwell BR. The therapeutic potential of targeting regulated non-apoptotic cell death. Nat Rev Drug Discov. 2023;22(9):723\u201342.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"3295_CR29","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1053\/j.gastro.2017.03.008","volume":"153","author":"SH Jiang","year":"2017","unstructured":"Jiang SH, Li J, Dong FY, Yang JY, Liu DJ, Yang XM, Wang YH, Yang MW, Fu XL, Zhang XX, et al. Increased Serotonin Signaling Contributes to the Warburg Effect in Pancreatic Tumor Cells Under Metabolic Stress and Promotes Growth of Pancreatic Tumors in Mice. Gastroenterology. 2017;153(1):277-291.e219.","journal-title":"Gastroenterology"},{"key":"3295_CR30","doi-asserted-by":"publisher","first-page":"1287459","DOI":"10.3389\/fimmu.2024.1287459","volume":"15","author":"C Hartupee","year":"2024","unstructured":"Hartupee C, Nagalo BM, Chabu CY, Tesfay MZ, Coleman-Barnett J, West JT, Moaven O. Pancreatic cancer tumor microenvironment is a major therapeutic barrier and target. Front Immunol. 2024;15:1287459.","journal-title":"Front Immunol"},{"issue":"4","key":"3295_CR31","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1080\/15548627.2020.1739447","volume":"17","author":"C Li","year":"2021","unstructured":"Li C, Zhang Y, Liu J, Kang R, Klionsky DJ, Tang D. Mitochondrial DNA stress triggers autophagy-dependent ferroptotic death. Autophagy. 2021;17(4):948\u201360.","journal-title":"Autophagy"},{"key":"3295_CR32","doi-asserted-by":"publisher","first-page":"e13644","DOI":"10.1111\/cpr.13644","volume":"57","author":"L Yu","year":"2024","unstructured":"Yu L, Huang K, Liao Y, Wang L, Sethi G, Ma Z. Targeting novel regulated cell death: Ferroptosis, pyroptosis and necroptosis in anti-PD-1\/PD-L1 cancer immunotherapy. Cell Prolif. 2024;57:e13644.","journal-title":"Cell Prolif"},{"issue":"4","key":"3295_CR33","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22(4):266\u201382.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6486","key":"3295_CR34","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1126\/science.aaw9872","volume":"368","author":"MA Badgley","year":"2020","unstructured":"Badgley MA, Kremer DM, Maurer HC, DelGiorno KE, Lee HJ, Purohit V, Sagalovskiy IR, Ma A, Kapilian J, Firl CEM, et al. Cysteine depletion induces pancreatic tumor ferroptosis in mice. Science (New York, NY). 2020;368(6486):85\u20139.","journal-title":"Science (New York, NY)"},{"issue":"2","key":"3295_CR35","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1158\/2159-8290.CD-20-0789","volume":"11","author":"E Koren","year":"2021","unstructured":"Koren E, Fuchs Y. Modes of Regulated Cell Death in Cancer. Cancer Discov. 2021;11(2):245\u201365.","journal-title":"Cancer Discov"},{"issue":"36","key":"3295_CR36","doi-asserted-by":"publisher","first-page":"eaaw2004","DOI":"10.1126\/sciimmunol.aaw2004","volume":"4","author":"AG Snyder","year":"2019","unstructured":"Snyder AG, Hubbard NW, Messmer MN, Kofman SB, Hagan CE, Orozco SL, Chiang K, Daniels BP, Baker D, Oberst A. Intratumoral activation of the necroptotic pathway components RIPK1 and RIPK3 potentiates antitumor immunity. Sci Immunol. 2019;4(36):eaaw2004.","journal-title":"Sci Immunol"},{"issue":"1","key":"3295_CR37","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13045-022-01392-3","volume":"15","author":"X Tong","year":"2022","unstructured":"Tong X, Tang R, Xiao M, Xu J, Wang W, Zhang B, Liu J, Yu X, Shi S. Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research. J Hematol Oncol. 2022;15(1):174.","journal-title":"J Hematol Oncol"},{"issue":"4","key":"3295_CR38","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.tcb.2023.07.009","volume":"34","author":"X Liu","year":"2024","unstructured":"Liu X, Zhuang L, Gan B. Disulfidptosis: disulfide stress-induced cell death. Trends Cell Biol. 2024;34(4):327\u201337.","journal-title":"Trends Cell Biol"},{"key":"3295_CR39","doi-asserted-by":"publisher","first-page":"13461","DOI":"10.2147\/CMAR.S268380","volume":"12","author":"B Yang","year":"2020","unstructured":"Yang B, Gu B, Zhang J, Xu L, Sun Y. CASC8 lncRNA Promotes the Proliferation of Retinoblastoma Cells Through Downregulating miR34a Methylation. Cancer Manag Res. 2020;12:13461\u20137.","journal-title":"Cancer Manag Res"},{"issue":"8","key":"3295_CR40","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1038\/s42255-023-00863-2","volume":"5","author":"T TeSlaa","year":"2023","unstructured":"TeSlaa T, Ralser M, Fan J, Rabinowitz JD. The pentose phosphate pathway in health and disease. Nat Metab. 2023;5(8):1275\u201389.","journal-title":"Nat Metab"},{"issue":"4","key":"3295_CR41","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/s41556-020-0496-x","volume":"22","author":"X Liu","year":"2020","unstructured":"Liu X, Olszewski K, Zhang Y, Lim EW, Shi J, Zhang X, Zhang J, Lee H, Koppula P, Lei G, et al. Cystine transporter regulation of pentose phosphate pathway dependency and disulfide stress exposes a targetable metabolic vulnerability in cancer. Nat Cell Biol. 2020;22(4):476\u201386.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"3295_CR42","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cell.2012.03.003","volume":"149","author":"CV Dang","year":"2012","unstructured":"Dang CV. MYC on the path to cancer. Cell. 2012;149(1):22\u201335.","journal-title":"Cell"},{"key":"3295_CR43","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.semcancer.2020.11.008","volume":"83","author":"H Fatma","year":"2022","unstructured":"Fatma H, Maurya SK, Siddique HR. Epigenetic modifications of c-MYC: Role in cancer cell reprogramming, progression and chemoresistance. Semin Cancer Biol. 2022;83:166\u201376.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"3295_CR44","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s13045-022-01348-7","volume":"15","author":"J Lin","year":"2022","unstructured":"Lin J, Wang X, Zhai S, Shi M, Peng C, Deng X, Fu D, Wang J, Shen B. Hypoxia-induced exosomal circPDK1 promotes pancreatic cancer glycolysis via c-myc activation by modulating miR-628-3p\/BPTF axis and degrading BIN1. J Hematol Oncol. 2022;15(1):128.","journal-title":"J Hematol Oncol"},{"key":"3295_CR45","doi-asserted-by":"publisher","first-page":"694071","DOI":"10.3389\/fcell.2021.694071","volume":"9","author":"D Che","year":"2021","unstructured":"Che D, Wang M, Sun J, Li B, Xu T, Lu Y, Pan H, Lu Z, Gu X. KRT6A Promotes Lung Cancer Cell Growth and Invasion Through MYC-Regulated Pentose Phosphate Pathway. Front Cell Dev Biol. 2021;9:694071.","journal-title":"Front Cell Dev Biol."},{"issue":"11","key":"3295_CR46","doi-asserted-by":"publisher","first-page":"5232","DOI":"10.7150\/thno.53417","volume":"11","author":"YC Tang","year":"2021","unstructured":"Tang YC, Hsiao JR, Jiang SS, Chang JY, Chu PY, Liu KJ, Fang HL, Lin LM, Chen HH, Huang YW, et al. c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation. Theranostics. 2021;11(11):5232\u201347.","journal-title":"Theranostics"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03295-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-025-03295-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03295-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T14:09:16Z","timestamp":1737986956000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-025-03295-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,27]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3295"],"URL":"https:\/\/doi.org\/10.1186\/s13046-025-03295-w","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,27]]},"assertion":[{"value":"29 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures related to patients were carried out in accordance with International Ethical Guidelines for Biomedical Research Involving Human Subjects (CIOMS).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors had agreed to publish this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have declared that no conflict of interest exists.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}